Elizabeth Holmes: Page 3
Thirteen years, a thousand employees, $700 million of venture capital, 40 wellness centers. Six million blood tests. Zero revenue. This is how it happened.
The company's 'core team' will continue development of a new miniLab.
In 2017, the company said, the board of counselors will be retired.
This is the first lawsuit against Theranos that's seeking class-action status.
It's accusing the controversial blood-testing company of lying to get its money.
As a result, the company will let 340 people go.
The California-based company ran into trouble after the Wall Street Journal published a series of articles that suggested its devices were flawed.
Those technologies included a new 'minilab' product that can run a broad range of tests on a single desktop machine.